Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.
Iwaki S, Kadowaki S, Honda K, Narita Y, Masuishi T, Taniguchi H, Ando M, Muro K, Sawabe M, Suzuki H, Nishikawa D, Beppu S, Terada H, Kishikawa T, Kawakita D, Hanai N.
Iwaki S, et al. Among authors: terada h.
Int J Clin Oncol. 2024 Jun;29(6):764-770. doi: 10.1007/s10147-024-02508-0. Epub 2024 Mar 30.
Int J Clin Oncol. 2024.
PMID: 38555323